Sandoz reaches agreement with Amgen resolving all patent litigation related to its US denosumab biosimilars
GlobeNewswire
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules
*Sandoz reaches agreement with Amgen resolving..